154 related articles for article (PubMed ID: 32736236)
1. Si-Miao-Yong-An Decoction attenuates isoprenaline-induced myocardial fibrosis in AMPK-driven Akt/mTOR and TGF-β/SMAD3 pathways.
Zhao Y; Sun D; Chen Y; Zhan K; Meng Q; Zhang X; Zhu L; Yao X
Biomed Pharmacother; 2020 Oct; 130():110522. PubMed ID: 32736236
[TBL] [Abstract][Full Text] [Related]
2. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
Su C; Wang Q; Luo H; Jiao W; Tang J; Li L; Tian L; Chen X; Liu B; Yu X; Li S; Guo S; Wang W
Biomed Pharmacother; 2020 Jul; 127():110132. PubMed ID: 32403042
[TBL] [Abstract][Full Text] [Related]
3. Dissection of mechanisms of Chinese medicinal formula Si-Miao-Yong-an decoction protects against cardiac hypertrophy and fibrosis in isoprenaline-induced heart failure.
Zhao Y; Jiang Y; Chen Y; Zhang F; Zhang X; Zhu L; Yao X
J Ethnopharmacol; 2020 Feb; 248():112050. PubMed ID: 31265887
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy.
Chen XY; Chen XH; Li L; Su CP; Zhang YL; Jiang YY; Guo SZ; Liu B
J Ethnopharmacol; 2021 May; 271():113833. PubMed ID: 33465437
[TBL] [Abstract][Full Text] [Related]
5. Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models.
Liao M; Xie Q; Zhao Y; Yang C; Lin C; Wang G; Liu B; Zhu L
Pharmacol Res; 2022 Feb; 176():106077. PubMed ID: 35026404
[TBL] [Abstract][Full Text] [Related]
6. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway.
Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W
Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891
[TBL] [Abstract][Full Text] [Related]
7. Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice.
Ren Y; Chen X; Li P; Zhang H; Su C; Zeng Z; Wu Y; Xie X; Wang Q; Han J; Guo S; Liu B; Wang W
Pharmacol Res; 2019 Aug; 146():104318. PubMed ID: 31228552
[TBL] [Abstract][Full Text] [Related]
8. Periplocymarin protects against myocardial fibrosis induced by β-adrenergic activation in mice.
Yun W; Qian L; Yuan R; Xu H
Biomed Pharmacother; 2021 Jul; 139():111562. PubMed ID: 33839492
[TBL] [Abstract][Full Text] [Related]
9. Chikusetsu saponin IVa attenuates isoprenaline-induced myocardial fibrosis in mice through activation autophagy mediated by AMPK/mTOR/ULK1 signaling.
Wang L; Yuan D; Zheng J; Wu X; Wang J; Liu X; He Y; Zhang C; Liu C; Wang T; Zhou Z
Phytomedicine; 2019 May; 58():152764. PubMed ID: 31005723
[TBL] [Abstract][Full Text] [Related]
10. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
Shi S; Liu Z; Xue Z; Chen X; Chu Y
J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
[TBL] [Abstract][Full Text] [Related]
11. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
[TBL] [Abstract][Full Text] [Related]
12. Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.
Song SL; Gong ZJ; Zhang QR; Huang TX
World J Gastroenterol; 2005 Apr; 11(15):2269-76. PubMed ID: 15818738
[TBL] [Abstract][Full Text] [Related]
13. Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.
Li L; Chen X; Su C; Wang Q; Li R; Jiao W; Luo H; Tian Y; Tang J; Li X; Liu B; Wang W; Zhang D; Guo S
Biomed Pharmacother; 2020 Dec; 132():110817. PubMed ID: 33068937
[TBL] [Abstract][Full Text] [Related]
14. Baicalin inhibits pressure overload-induced cardiac fibrosis through regulating AMPK/TGF-β/Smads signaling pathway.
Xiao Y; Ye J; Zhou Y; Huang J; Liu X; Huang B; Zhu L; Wu B; Zhang G; Cai Y
Arch Biochem Biophys; 2018 Feb; 640():37-46. PubMed ID: 29331689
[TBL] [Abstract][Full Text] [Related]
15. Taohong siwu decoction attenuates myocardial fibrosis by inhibiting fibrosis proliferation and collagen deposition via TGFBR1 signaling pathway.
Tan Z; Jiang X; Zhou W; Deng B; Cai M; Deng S; Xu Y; Ding W; Chen G; Chen R; Zhang S; Zhou Y; Liu B; Zhang J
J Ethnopharmacol; 2021 Apr; 270():113838. PubMed ID: 33460756
[TBL] [Abstract][Full Text] [Related]
16. Bao Yuan decoction and Tao Hong Si Wu decoction improve lung structural remodeling in a rat model of myocardial infarction: Possible involvement of suppression of inflammation and fibrosis and regulation of the TGF-β1/Smad3 and NF-κB pathways.
Yuan G; Han A; Wu J; Lu Y; Zhang D; Sun Y; Zhang J; Zhao M; Zhang B; Cui X
Biosci Trends; 2018; 12(5):491-501. PubMed ID: 30473557
[TBL] [Abstract][Full Text] [Related]
17. Xiaoyaosan decoction alleviated rat liver fibrosis via the TGFβ/Smad and Akt/FoxO3 signaling pathways based on network pharmacology analysis.
Zhou Y; Wu R; Cai FF; Zhou WJ; Lu YY; Zhang H; Chen QL; Su SB
J Ethnopharmacol; 2021 Jan; 264():113021. PubMed ID: 32479885
[TBL] [Abstract][Full Text] [Related]
18. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
[TBL] [Abstract][Full Text] [Related]
19. Si-Miao-Yong-An Decoction Maintains the Cardiac Function and Protects Cardiomyocytes from Myocardial Ischemia and Reperfusion Injury.
Cui W; Xin S; Zhu L; Wang M; Hao Y; Zhao Y; Li Y; Hou Y
Evid Based Complement Alternat Med; 2021; 2021():8968464. PubMed ID: 34367308
[TBL] [Abstract][Full Text] [Related]
20. Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis.
Wu T; Chu H; Tu W; Song M; Chen D; Yuan J; Yu L; Ma Y; Liu Q; Jin L; Zhou X; Zou H; Wu W; Wang J
BMC Complement Altern Med; 2014 Jul; 14():224. PubMed ID: 24998426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
